Clinical Trial

Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Unknown Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated June 9, 2023 (before its estimated August 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, single-arm, open-label，multi-center, phase II study, aiming to evaluate the efficacy and safety of AK104 combined with preoperative chemotherapy in patients with locally advanced ESCC.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05896787
Lead Sponsor The First Affiliated Hospital of Zhengzhou University
Conditions Esophageal Squamous Cell Carcinoma
Enrollment 45 participants
Start Date 2023-08-01
Primary Completion 2024-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2023-06-09